APOC1 inhibit NKTCL doxorubicin sensitivity by promoting mitophagy.
Xiao S, Kuang J, Yang J, Wang H, Sun Y, Zhang H, Zhang Z, Shi M, Qi K, Jiang M, Zhang Y, Chen Q, Zhang X.
Xiao S, et al. Among authors: zhang z.
IUBMB Life. 2025 Jan;77(1):e2942. doi: 10.1002/iub.2942.
IUBMB Life. 2025.
PMID: 39817465